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Transcriptome profiling has shown that the pro-apoptotic
death-domain-associated protein Daxx is rapidly induced in
the kidney of animals following ischemic injury. Here we
found that Daxx protein was increased 5-fold in tubule cells
in both animal and human models of ischemic acute kidney
injury. Further there was upregulation of its primary
interacting partner, Fas and phosphorylation of its primary
downstream activator (JNK) in parallel to Daxx induction. In
cultured tubule cells, partial ATP depletion resulted in a rapid
induction of Daxx, Fas, JNK phosphorylation and apoptosis.
Antisense oligonucleotides to Daxx and specific JNK
inhibitors blunted the apoptotic response to ATP depletion.
These studies indicate that Daxx may play an unrecognized
role in the early apoptotic response to ischemic renal injury.
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Acute kidney injury (AKI), previously referred to as acute
renal failure, remains a common and devastating problem,
with a persistently high mortality rate despite advances in
supportive care.1,2 Ischemia–reperfusion injury is the leading
cause of AKI in both the native and the transplanted kidney.3
Advances in basic research have illuminated the pathogenesis
of AKI and unveiled potential therapeutic approaches in
animal models.3 However, translational research efforts in
humans have yielded disappointing results, at least in part
due to an incomplete understanding of the underlying
cellular and molecular mechanisms.4 Mounting evidence now
indicates that both apoptosis and necrosis constitute
important mechanisms of early tubule cell death in AKI.5,6
In general, necrosis appears to predominate in proximal
tubule cells whereas distal tubules are more prone to
apoptotic cell death. Several cell culture and animal models
of ischemic AKI have consistently demonstrated the presence
of apoptotic and necrotic changes in tubule cells.4–10
Importantly, this has now been confirmed in human models
of AKI,11 and considerable attention has therefore been
directed toward dissecting out the molecular pathways
involved.3
Attempts at unraveling the apoptotic pathways have been
accelerated by cDNA microarray-based technologies.12 We
have previously shown using genome-wide transcriptome
profiling that a sub-set of putative proapoptotic molecules
are rapidly induced following ischemic AKI in animal
models.7 These included members of the intrinsic mitochon-
drial pathway (BAD and BAK), the extrinsic death receptor
pathway (Fas-associated death domain and Daxx), and the
regulatory pathway (p53). In this study, we chose to further
characterize Daxx, an enigmatic molecule whose function
remains highly controversial.13 Daxx, or death-domain-
associated protein, was first identified as a protein that
specifically binds to the death domain of the proapoptotic
receptor Fas, and potentiates Fas-mediated apoptosis.14
Subsequent studies have indicated that Daxx-dependent cell
death involves the phosphorylation of Jun N-terminal kinase
(JNK) and subsequent activation of caspase-9-dependent
mitochondrial apoptotic pathways.15,16 However, targeted
disruption of the Daxx gene in mice resulted in a paradoxical
induction of apoptosis, suggesting that during early deve-
lopment, Daxx may suppress apoptosis.17 Depletion of
endogenous Daxx by RNA interference also resulted in
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increased apoptosis in cultured cells, again suggesting an
antiapoptotic function.18,19
Relatively little is known about the role of Daxx in the
kidney. In cultured HeLa cells, upregulation of Daxx has been
shown to mediate oxidative stress-induced apoptosis,16,20 and
there is evidence for Daxx as a potentiator of p53-dependent
apoptotic pathways.21–23 Since oxidative stress as well as p53
induction have both been implicated in the pathogenesis of
AKI,3 we hypothesized that Daxx may play a role in the
apoptotic tubule cell death following renal ischemia–reperfu-
sion injury. To test our hypothesis, we characterized the
expression of Daxx, Fas (its primary interacting protein) and
JNK (its primary downstream activator) in animal, human,
and cell culture models of ischemic AKI. Our results indicate
that Daxx may play a hitherto unrecognized role in the early
apoptotic response to ischemic renal injury.
RESULTS
Induction of Daxx and Fas, and activation of JNK in mouse
kidney
We hypothesized that Daxx may play a role in the apoptotic
tubule cell death following renal ischemia–reperfusion injury.
To test our hypothesis, we first characterized the expression
of Daxx, Fas (its primary interacting protein), and JNK (its
primary downstream activator) in an established animal
model of ischemic AKI. By western blot analysis, Daxx in
control kidney lysates was just detectable as a 120-kDa
immunoreactive peptide, as shown in Figure 1. Examination
of lysates obtained at various periods of reflow following
kidney ischemia confirmed the early and robust induction of
Daxx protein with 3 h of reperfusion, as suggested by our
previous mRNA expression analysis.7 By densitometric
analysis of six independent experiments, the fold increase
in Daxx protein expression was found to be 4.2±2 at 3 h,
5.5±3 at 12 h, and 5.1±1 at 24 h of reflow. These changes
were closely paralleled by a similar induction of Fas, which
was identified as a 50-kDa peptide in control kidney lysates
and induced approximately fourfold within 3 h of reperfu-
sion. Furthermore, we employed an antibody to phospho-
JNK (which recognizes only the phosphorylated p46 and p54
forms) to illustrate the absence of JNK activation in control
kidney lysates and the prompt activation of JNK within 3 h of
reperfusion (Figure 1).
Localization of Daxx and apoptosis in mouse and human
kidney
Using immunohistochemical techniques, we next demon-
strated that Daxx protein was barely detectable in control
mouse kidneys, but was markedly and uniformly upregulated
in both proximal and distal nephron segments following
ischemia (Figure 2). This was evident within 3 h, and further
accentuated at later time points. Within these epithelial cells,
Daxx was initially expressed primarily in a diffuse cytoplas-
mic pattern, but at later time points (12 and 24 h of
reperfusion) in the nucleus as well. The glomeruli and
interstitium were devoid of Daxx staining.
To better illustrate the nuclear staining of Daxx and to
correlate it with the induction of apoptosis, we next
examined serial sections of mouse kidneys by immuno-
histochemistry for Daxx expression as well as terminal
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Figure 1 | Induction of Daxx and Fas protein, and activation of
JNK, after kidney ischemia. Representative western blots with
whole kidney lysates obtained from control (Con.) mice or after
30 min ischemia and reperfusion periods as shown (hours),
probed with antibodies to Daxx, Fas, phospho-JNK, and tubulin
(to demonstrate equal protein loading) as shown. Kidney Daxx
and Fas protein were coordinately induced very early following
ischemic injury, accompanied by activation of JNK. The figure
represents results from six independent experiments.
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Figure 2 | Immunolocalization of Daxx protein after kidney
ischemia. Representative immunohistochemical results on frozen
sections of mouse kidneys obtained from control (Con.) animals or
after 30 min ischemia and reperfusion periods as shown (hours),
probed with antibody to Daxx. Ischemia–reperfusion injury
resulted in Daxx upregulation in both proximal and distal nephron
segments. Results were reproducible in six experiments.
G, glomerulus.
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deoxynucleotidedyl transferase (Tunel) assay for definition of
apoptotic nuclei. As shown in Figure 3, tubules that were
positive for Daxx staining also revealed Tunel-positive
apoptotic nuclei, and tubules that were devoid of Daxx
staining were largely negative for apoptosis. In particular,
tubule cells exhibiting nuclear Daxx staining also displayed
fragmented Tunel-positive nuclei characteristic of apoptotic
changes. These findings were present predominantly in distal
nephron segments, but also in proximal tubule cells. These
findings were confirmed in a human model of renal
ischemia–reperfusion injury, namely kidney biopsy samples
from cadaveric kidney allografts, which revealed similar
colocalization of Daxx- and Tunel-positive apoptotic nuclei,
in both distal and proximal tubule cells (Figure 3).
Induction of Daxx and Fas protein in RPTECs by ATP
depletion
We next examined the expression of Daxx and Fas protein in
cultured human proximal tubule cells subjected to mild
ischemic injury by partial ATP depletion. Incubation of renal
proximal tubular epithelial cells (RPTECs) cells in 1 mm
antimycin resulted in a mild partial ATP depletion to about
83±3% of control within 1 h, with a more gradual decrease
to about 75±3% of control by 6 h(mean±s.d. from six
experiments). This resulted in a dramatic apoptotic response
within 12 h, as demonstrated by DNA laddering as well as
Tunel-positive apoptotic nuclei (Figure 4). Daxx protein was
just detectable in resting cells as a 120-kDa immunoreactive
peptide (Figure 4). Following partial ATP depletion, a rapid
induction of Daxx protein was evident within 6 h. Similarly,
Fas protein was detectable as a 50-kDa species in control cells,
and there was a rapid and parallel increase in Fas protein
expression following ATP depletion. Furthermore, there was
an absence of JNK activation in control cell lysates, and a
prompt activation of JNK within 6 h of ATP depletion. Thus,
the responses of Daxx, Fas, and JNK were similar in an
animal model and in a cell culture model of ischemic kidney
injury.
Inhibition of the Daxx response to ATP depletion by
antisense primers
To explore the functional consequences of Daxx induction,
we designed antisense oligonucleotide experiments to down-
regulate the expression of Daxx. Incubation of RPTECs with
a phosphorothioated antisense primer to Daxx dramatically
blunted the response of Daxx protein to ATP depletion, as
shown in Figure 5. Whereas cells exposed to sense Daxx
primers exhibited rapid induction of Daxx protein following
ATP depletion, expression of Daxx in cells incubated with
antisense Daxx primers remained largely unaltered. Similarly,
whereas cells incubated with sense Daxx primers displayed a
robust activation of JNK in a parallel manner to Daxx, the
antisense Daxx primers abrogated this JNK response to ATP
depletion. Interestingly, whereas cells incubated with sense
Daxx primers displayed induction of Fas in a parallel manner
to Daxx, the antisense Daxx primers did not abrogate this Fas
response to ATP depletion. These results suggest that the
upregulation of Daxx protein in RPTECs following ATP
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Figure 3 | Immunolocalization of Daxx protein and apoptosis
after kidney ischemia. Representative immunohistochemical
results on sections of mouse kidneys obtained from animals after
30 min ischemia and 12 h of reperfusion (left two panels), or on
human cadaveric kidneys (right two panels). Serial sections were
probed with antibody to Daxx (top two panels) and Tunel assay
(bottom two panel). Arrows show tubule cells that were positive
for both Daxx and Tunel-positive apoptotic nuclei, and asterisks
indicate tubules that were negative for both. Results were
reproducible in six experiments.
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Figure 4 | Induction of apoptosis, Daxx, Fas, and activated JNK
in RPTEC cells after ATP depletion. Left panel shows DNA
laddering after 12 or 24 h of ATP depletion. Middle panel shows
Tunel-positive nuclei after 12 h of ATP depletion. Representative
western blots with samples obtained from control (Con.) RPTECs
or after partial ATP depletion periods as shown (hours), probed
with antibodies to Daxx, Fas, phospho-JNK, and tubulin (to
demonstrate equal protein loading). RPTEC Zf9 and TGF-b1
protein were markedly and coordinately induced very early
following ATP depletion. Results were reproducible in six
experiments.
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depletion is independent of Fas induction, and that Fas
upregulation may occur upstream of Daxx induction.
It was next of importance to examine the apoptotic
response of RPTECs to partial ATP depletion with concurrent
Daxx and JNK inhibition. Cells incubated with medium
alone (control group, containing no primers) or with sense
Daxx primers displayed significant apoptosis following 12 h
of partial ATP depletion. This was quantified by Tunel assay
as shown in Figure 6. In contrast, cells incubated with
antisense Daxx primers displayed significant blunting of the
apoptotic response to ATP depletion. Whereas apoptosis rate
following ATP depletion in cells transfected with sense Daxx
primer was 33±4 cells per 100 cells examined (similar to the
control group containing no primers), incubation with
antisense Daxx primer dramatically reduced apoptosis rate
to 15±4 cells per 100 cells counted. However, despite Daxx
and JNK inhibition, this rate remained significantly above
control non-ischemic cells, which displayed a basal apoptosis
rate of only 3±1 cells per 100 cells examined.
To confirm that inhibition of Daxx and JNK with Daxx
antisense primers affected apoptosis, we assayed for caspase-9
activity since JNK activation induces primarily the caspase-9
dependent intrinsic apoptotic pathway. Caspase-9 activity
was expressed as fold changes from a baseline pre-ischemic
state. The caspase-9 activity following ATP depletion in cells
transfected with sense Daxx primer was increased by an
average of 4.5-fold from baseline (similar to the control
group containing no primers), as illustrated in Figure 7. This
response of caspase-9 was significantly blunted in cells
incubated with antisense Daxx primer, in which caspase-9
activity was increased only by about 2.5-fold from baseline.
However, this rate remained significantly above that of
control non-ischemic cells.
Inhibition of the JNK response to ATP depletion by specific
JNK inhibitors
To specifically investigate the role of JNK activation, a
specific, cell-penetrating, protease-resistant JNK inhibitor
(D-JNKI1) was employed before and during partial ATP
depletion to suppress the JNK response. In preliminary
studies, D-JNKI1 in the dose of 1 mM was not effective in
suppressing JNK activity in our model of in vitro ischemic
injury, and a dose of 2 mM was not efficacious when
administered concomitant with antimycin A (not shown).
However, D-JNKI1 at 2mM applied 2 h prior to the start of
ATP depletion resulted in a significant reduction of JNK
activation by western blot analysis (Figure 8). Consequently,
we examined the apoptotic response of RPTECs to partial
ATP depletion with specific JNK inhibition. Cells incubated
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Figure 5 | Inhibition of Daxx by antisense primers.
Representative western blots with samples obtained from control
(Con.) RPTECs or after partial ATP depletion periods as shown
(hours), in the presence of sense or antisense Daxx
oligonucleotides, probed with antibodies to Daxx, pJNK, Fas, and
tubulin (to demonstrate equal protein loading). The induction of
Daxx and pJNK, but not of Fas, was markedly suppressed by
antisense Daxx primer. Results were reproducible in six
independent experiments.
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Figure 6 | Inhibition of apoptosis by antisense Daxx primers.
Results of Tunel assays with samples obtained from control (C)
RPTECs or after partial ATP depletion for 12 h (ischemic) in the
presence of sense (S) or antisense (AS) Daxx oligonucleotides. The
expected induction of apoptosis by ATP depletion was
significantly, but not completely, suppressed by antisense Daxx
primers. *Po0.05 versus control. Values are means±s.d. from six
experiments.
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Figure 7 | Inhibition of caspase-9 activation by antisense Daxx
primers. Results of caspase-9 assays with samples obtained from
control (C) RPTECs or after partial ATP depletion for 12 h
(ischemic) in the presence of sense (S) or antisense (AS) Daxx
oligonucleotides. The 4.5-fold induction of caspase-9 by ATP
depletion was significantly, but not completely, suppressed by
antisense Daxx primers. *Po0.05 versus control. Values are
means±s.d. from four experiments.
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with medium alone (control group, containing no inhibitor)
displayed significant apoptosis following 12 h of partial ATP
depletion. This was quantified by Tunel assay as shown in
Figure 8. In contrast, cells incubated with D-JNKI1 displayed
a significant blunting of the apoptotic response to ATP
depletion. Whereas apoptosis rate following ATP depletion in
control cells 42±5 cells per 100 cells examined, incubation
with D-JNKI1 dramatically reduced apoptosis rate to 22±5
cells per 100 cells counted. This blunting of the apoptotic
response was similar to that seen with Daxx antisense
primers. However, despite JNK inhibition, this rate remained
significantly above control non-ischemic cells, which dis-
played a basal apoptosis rate of only 3.2±1 cells per 100 cells
examined.
To confirm that the JNK inhibitor affected apoptosis, we
assayed for caspase-9 activity, which was expressed as fold
changes from a baseline pre-ischemic state. The caspase-9
activity following ATP depletion in cells incubated with
medium alone (control group, containing no inhibitor) was
increased by an average of 4.5-fold from baseline, as
illustrated in Figure 8. This response of caspase-9 was
significantly blunted in cells incubated with D-JNKI1, in
which caspase-9 activity was increased only by about 2.5-fold
from baseline. This blunting of the caspase-9 response was
similar to that seen with Daxx antisense primers. However,
this rate remained significantly above that of control non-
ischemic cells.
DISCUSSION
This study demonstrates the rapid upregulation of both Daxx
and Fas, and activation of JNK, in kidney tubules of animal
and human models of ischemia reperfusion injury as well as
cultured human tubule cells. Our results indicate that these
proteins may play a role in the early apoptotic response to
ischemic renal injury.
Daxx, a puzzling molecule whose function remains poorly
understood, was first identified as a protein that specifically
binds to the proapoptotic receptor Fas, and potentiates
Fas-mediated apoptosis in the concurrent presence of Fas
overexpression.13,14 A number of other Daxx-interacting
partners have now been identified, including the proapopto-
tic kinase ASK1 and transcription factors such as p53,
Pax3, Pax5, and Smad4.13 Daxx protein is upregulated
following several apoptotic stimuli, including oxidative
stress,16,20 and induction of p53.21–23 The induced Daxx
accumulates both in the cytoplasm and the nucleus.
Subsequent studies revealed that Daxx-dependent apoptotic
pathways frequently involve the downstream activation of
JNK.15,16 However, knockout of the Daxx gene in mice
resulted in a paradoxical induction of apoptosis, and
depletion of Daxx by RNA interference resulted in increased
apoptosis in cultured cells, both suggesting an unexpected
antiapoptotic function.17–19
Daxx is known to be expressed in the kidney, but little is
known about its role. In control mouse kidneys, Daxx protein
is expressed at a low level in both proximal and distal tubule
cells, in a diffuse cytoplasmic distribution. The physiological
role of cytoplasmic Daxx in resting cells is unknown,
although it may be speculated that Daxx may contribute to
the maintenance of cellular homeostasis by binding to
proapoptotic transcription factors.13 Daxx is one of the
robustly induced genes in the kidney in the early phases of
ischemia–reperfusion injury.7 In this study, we demonstrate
that the translated protein product followed the same
pattern, being induced about fivefold at the 12 h reperfusion
period, in a nuclear as well as cytoplasmic distribution in
tubule epithelial cells.
The localization and temporal pattern of Daxx expression
is suggestive of a role in the immediate-early response of
kidney tubule cells to ischemic injury, which includes cell
death due to apoptosis and necrosis.3 Since Daxx protein is
overexpressed in both distal tubules (which predominantly
undergo apoptosis following ischemia–reperfusion injury)
and proximal nephron segments (where necrotic cell death
may predominate), it is intriguing to speculate that Daxx
may play a role in both these processes. This would be
consistent with the dual role attributed to Daxx’s primary
downstream effector, JNK, which has been shown to induce
both apoptosis as well as necrosis.24–28 Our studies do not
permit a completely reliable distinction between apoptosis
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Figure 8 | Inhibition of apoptosis and caspase-9 activation by JNK inhibitor. Results of western blots (left panel), Tunel assays
(middle panel), and caspase-9 assays (right panel) with samples obtained from RPTECs at baseline or after partial ATP depletion for
12 h (ischemic) in the presence of D-JNKI1 (Inh.) or absence of inhibitor (Con.). The expected activation of phospho-JNK (pJNK), induction of
apoptosis, and activation of caspase-9 by ATP depletion were significantly, but not completely, suppressed by D-JNKI1. *Po0.05 versus
control. Values are means±s.d. from four experiments.
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and necrosis in the tubule cells overexpressing Daxx.
Although we demonstrate colocalization of Daxx with
Tunel-positive nuclei, it is acknowledged that (a) both
apoptotic and necrotic cells may exhibit Tunel positivity,
and that (c) Tunel positivity may also result from Daxx-
independent apoptotic mechanisms.
Several recent studies have documented that brief periods
of ischemia in animal models leads to apoptosis of distal
tubule epithelial cells within 3–12 h of the injury,4–10 at the
same time that Daxx is maximally induced. The occurrence
of early-onset apoptosis has now been confirmed in biopsy
samples from transplanted cadaveric kidneys, which consti-
tutes a human model for renal ischemia–reperfusion injury.11
Several scenarios may be envisioned to explain the loss of
renal function following tubule cell apoptosis. First, the
apoptotic cells are rapidly phagocytosed (either by neighbor-
ing cells or by macrophages), which can result in denuded
areas of dysfunctional tubular epithelium. Second, the
apoptotic cells undergo sloughing and desquamation, with
resultant luminal obstruction. Third, although apoptosis is
generally not associated with an inflammatory response,
apoptotic kidney tubule cells may mount a ‘maladaptive
response’ by upregulating proinflammatory and chemotactic
cytokines that mediate the inflammation prominently seen in
ischemic AKI.
In both animal and human models of ischemia–reperfu-
sion injury, Daxx was noted to be induced both in the
cytoplasm and the nucleus. The molecular sequence of Daxx
reveals that it contains two nuclear localization signals, and
Daxx has also been reported in other cell types to localize to
the nucleus.17 While the role of Daxx in the nucleus remains
debated, it has been shown to colocalize to sub-nuclear
structures containing the promyelocytic leukemia protein.29
This suggests one potential mechanism underlying Daxx-
induced apoptosis, since promyelocytic leukemia protein is a
proapoptotic molecule and overexpression of promyelocytic
leukemia protein induces cell death, whereas promyelocytic
leukemia protein-deficient mice display resistance to apop-
tosis. In addition, nuclear Daxx may act as a transcriptional
regulator, and modulate the expression of other proapoptotic
genes such as Fas.30
Since downregulation of apoptosis may offer a therapeutic
approach to ischemia–reperfusion injury in both the native
and the transplanted kidney, considerable efforts have
consequently been directed toward identification of the
intracellular pathways involved in the ischemia-induced
tubule cell death. It was, therefore, of interest to examine
both upstream as well as downstream targets of Daxx that
may play a role in renal cell apoptosis and necrosis.
Accumulating evidence has suggested that Fas is an
important mediator of tubule cell apoptosis following
ischemic injury in cultured cells,31 animal models,3,7,9 and
in human cadaveric kidneys.11 Recent studies in mice have
demonstrated the functional protection against renal ische-
mia–reperfusion injury afforded by small interfering RNA
duplexes targeting the Fas gene.32 In this paper, we have
demonstrated a rapid induction of Fas protein, in a temporal
pattern similar to that of Daxx, in mouse models as well as in
cultured human proximal tubule cells. Indeed, there may
exist a positive feedback loop whereby activated Daxx
translocates to the nucleus and induces transcription of
proapoptotic genes such as Fas.30 In some cell types, Daxx
potentiates Fas-mediated apoptosis in the concurrent pre-
sence of Fas overexpression.14 However, inhibition of Daxx
transcription using antisense oligonucleotide technology
prevented upregulation of Daxx, but did not abrogate the
Fas response to ATP depletion. These results suggest that
upregulation of Daxx protein is independent of Fas
induction, which presumably occurs upstream of Daxx
induction. Not surprisingly, Daxx inhibition only partially
suppressed the apoptotic response, presumably due to
continued induction of apoptosis via the canonical Fas
pathway based on recruitment of the Fas-associated death
domain protein Fas-associated death domain and consequent
activation of caspase-8.3,7,9,31 Indeed, overexpression of a Fas
death domain mutant that selectively binds Daxx, but not
Fas-associated death domain, resulted in JNK activation, but
failed to induce apoptosis in cultured human embryonic
kidney cells,15 highlighting the importance of the canonical
Fas–Fas-associated death domain–caspase-8 pathway over the
Daxx–JNK–caspase-9 pathway, at least in certain cell types.
On the other hand, cell-permeant caspase inhibitors have
generally provided only partial protection from ischemia–r-
eperfusion injury, and are most effective when administered
before the injurious stimulus is applied.33 Further under-
standing of the mechanism of Daxx-dependent pathways may
be provided in future studies by examining the effect of Daxx
inhibition in vivo.
JNK isoforms are stress-activated protein kinases that are
activated by Daxx and ASK1, and are leading signal
transduction candidates in ischemic cell death.34,35 Once
activated, JNK signaling targets the mitochondria by indu-
cing the translocation of Bax and release of cytochrome c,
which in turn activates the intrinsic apoptotic pathway.36,37
Activation of JNK has also been associated with caspase-
independent forms of cell death, including necrosis and
autophagy.38 Activation of JNK signaling has previously been
demonstrated in the kidney following oxidative and ische-
mia–reperfusion injury.39,40 In this study, we have demon-
strated a rapid phosphorylation of JNK, in a temporal pattern
similar to that of Daxx, in mouse models as well as in
cultured human proximal tubule cells. Inhibition of Daxx in
vitro prevented activation of JNK, and partially suppressed
activation of caspase-9 and the apoptotic response. Further-
more, specific, cell-permeant inhibitors of JNK resulted in
blunting of caspase-9 activation as well as apoptosis in a
manner quantitatively quite similar to that seen with Daxx
gene silencing. Our results indicate that, at least in cultured
renal epithelial cells subjected to ATP depletion, Daxx
induces cell death primarily via activation of JNK and a
downstream mitochondrial apoptotic pathway. However, in
the final analysis, both Daxx gene silencing as well as specific
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JNK inhibition resulted only in about a 50% decrease in
apoptosis, suggesting that either other apoptotic pathways
and/or necrotic mechanisms are also activated following ATP
depletion.
It is important to acknowledge that the in vitro model
(ATP depletion) used in our study may not be equivalent to
the in vivo conditions, where cell death appears to be induced
during the reperfusion phase by which time ATP levels start
recovering. It will, therefore, be important in future studies to
examine the pattern of JNK isoform expression in the normal
kidney, and to determine the role of differential JNK isoform
activation in the post-ischemic kidney. Examination of
isoform-specific JNK-knockout mice may facilitate further
elucidation of the role of this pathway in renal ischemia–r-
eperfusion injury, as has been demonstrated for apoptotic cell
death in ischemic brain injury.41,42 The potential of JNK
inhibitors as therapeutic agents has attracted considerable
interest in recent years, and there is accumulating evidence
supporting the use of JNK inhibitors in inflammatory,
vascular, neuronal, and metabolic diseases in humans.24–28
The commercial availability of specific cell-permeant peptide
inhibitors of JNK1 and JNK2 holds promise for enhancing
our understanding of the role of JNK isoforms in the kidney
in vivo. They may also provide novel tools to ameliorate, at
least in part, the early phases of ischemic ARF, a common
human condition associated with both apoptotic and
necrotic tubule cell death.
MATERIALS AND METHODS
Mouse models of renal ischemia–reperfusion injury
We used well-established murine models in which the structural and
functional consequences of renal ischemia–reperfusion injury have
been documented previously.7,9,43 Briefly, male Swiss–Webster mice
(Taconic Farms, Germantown, NY, USA) weighing 25–30 g were
housed with a 12:12 h light:dark cycle and were allowed free access
to food and water. The animals were anesthetized with a mixture of
isoflurane (2%) and oxygen (0.8 l/min), delivered using the Ohmeda
Excel 210 Anesthesia Machine (AKW Medical, El Cajon, CA, USA).
Animals were then placed on a warming table to maintain a rectal
temperature of 37 1C, since changes in body temperature may be
associated with alterations in kidney function. Both renal pedicles
were occluded with a non-traumatic vascular clamp for 30 min,
during which time the kidney was kept warm and moist. The clamps
were then removed, the kidney observed for return of blood flow,
and the incision sutured. The mice were allowed to recover in a
warmed cage. After various reperfusion periods, the animals were
re-anesthetized, killed, the kidneys perfusion fixed in situ with 4%
paraformaldehyde in phosphate-buffered saline, and both kidneys
harvested. One half of each kidney was snap frozen in liquid
nitrogen and stored at 70 1C until further processing. The other
half of each kidney was embedded in OCT compound (Tissue-Tek)
and frozen sections (4 mm) obtained for immunohistochemistry.
The functional derangements and histopathological features of this
model have been characterized previously.7,9,43 These included an
elevation in serum creatinine (2.5±0.6 mg/dl in the 24 h reflow
animals versus 0.6±0.3 mg/dl in the control group, Po0.05), loss of
brush border membranes, tubular dilatation, flattened tubular
epithelium, luminal debris, and an interstitial infiltrate. Also evident
were tubule epithelial cells displaying the characteristic morphology
of apoptotic nuclei as previously described.7,9,43
Western analysis
Kidney tissue samples were homogenized in ice-cold isolation
solution (250 mM sucrose, 10 mM triethanolamine, 1 Complete
protease inhibitor, pH 7.5) using a Polytron homogenizer. The
homogenate was centrifuged at low speed (1,000 g) for 10 min at
4 1C to remove cellular debris. Protein concentrations of the
supernates were determined by Bradford assay (Bio-Rad, Hercules,
CA, USA). Equal amounts of total protein were loaded in each lane
and subjected to SDS-polyacrylamide gel electrophoresis. Immuno-
detection of transferred proteins was achieved using enhanced
chemiluminescence (Amersham, Arlington Heights, IL, USA).
Immunostaining
For Daxx detection by standard immunohistochemistry, frozen
mouse kidney sections were permeabilized with 0.2% Triton X-100
in phosphate-buffered saline for 10 min, blocked with goat serum
for 1 h, and incubated with primary antibodies for 1 h. Slides were
then exposed for 60 min to biotinylated secondary antibody,
incubated for 30 min in horseradish peroxidase–streptavidin com-
plex, developed for 5 min with horseradish peroxidase substrate
mixture (ImmunoCruz Staining Systems; Santa Cruz Biotechnology,
Santa Cruz, CA, USA), counterstained with hematoxylin, and
visualized with a microscope (Zeiss Axiophot). For better definition
of nuclear Daxx staining and correlation with apoptotic nuclei,
frozen mouse kidney sections were processed and stained with Daxx
primary antibody as above, and with a secondary antibody
conjugated with Cy5 (Amersham). Serial sections were examined
by Tunel staining to identify apoptotic nuclei, as previously
described.7
Human biopsy material
We used left-over kidney biopsy samples previously obtained from
allografts at 1 h of reperfusion after release of the vascular clamps
during cadaveric kidney transplantation.11 Paraffin-embedded
kidney biopsy samples from six cadaveric recipients who had
previously consented to a study approved by the Institutional
Review Board for examination of apoptotic pathways, were available
for examination by Daxx immunohistochemistry and Tunel
staining, as previously described.11
Cell culture
Human RPTECs were obtained from Clonetics (San Diego, CA,
USA). Cells were grown in renal epithelial cell basal medium
supplemented with renal epithelial growth medium complex (0.5 ml/
ml hydrocortisone, 10 pg/ml human epidermal growth factor,
0.5 mg/ml epinephrine, 6.5 pg/ml triiodothyronine, 10 mg/ml trans-
ferrin, 5 mg/ml insulin, 1 mg/ml gentamicin sulfate, and 2% fetal
bovine serum), as recommended by the manufacturer. We modified
the previously described protocols of in vitro ischemia by ATP
depletion with inhibitors of oxidative phosphorylation.4,31,44 On the
second day post confluence, RPTECs were incubated with 1 mm
antimycin A (Sigma, St Louis, MO, USA) for varying periods of
time up to 12 h. We have previously shown that this results in mild
partial ATP depletion in cultured renal epithelial cells such as
Madin–Darby canine kidney,31 786-O,44 and RPTECs4. ATP levels
were monitored using a luciferase-based assay kit (Sigma) and
expressed as a percentage of control values. Cells were harvested at
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various time points of ATP depletion and subjected to western blot
analysis as previously described.4
Antisense oligonucleotides to Daxx
Phosphorothioated antisense and sense oligonucleotides directed to
the translation initiation site of human Daxx were synthesized as
follows:
antisense, 50-GCTGTTAGCGGTGGCCATAGGGG-30;
sense, 50-CCCCTATGGCCACCGCTAACAGC-30.
RPTECs were grown to 80% confluence and washed with Opti-
MEM (Life Technologies, Gaithersburg, MD, USA). Oligonucleo-
tides (final concentration 10 mM) were incubated in 10 mg/ml
lipofectamine reagent (Life Technologies) in Opti-MEM for
30 min at room temperature and then applied to the washed cells
for 5 h at 37 1C4 The control group of cells was incubated in the
same medium, but in the absence of primers. The medium was
removed, cells washed and incubated in standard growth medium
for 24 h, and were subjected to partial ATP depletion by incubating
with 1 mm antimycin A (Sigma) for varying periods of time up to
12 h. Cells were harvested at various time points of ATP depletion
and analyzed for protein expression by western blot analysis and
apoptosis assays as detailed below.
JNK inhibitors
The specific, cell-penetrating, protease-resistant JNK inhibitor D-JNKI1
(Alexis Biochemicals, San Diego, CA, USA) was employed to inhibit
JNK activation in vitro, as previously described.24–28 Briefly, RPTECs
were pretreated with D-JNKI1 (2mm) for 2 h and subjected to partial
ATP depletion by addition of 1mm antimycin A for a period of 12 h.
Cells were harvested and analyzed for protein expression by western
blot analysis and apoptosis assays as detailed below.
Apoptosis assays
RPTECs were subjected to the DNA laddering assay for detection of
apoptosis as previously described.4 Briefly, cells were resuspended in
lysis buffer (1% SDS, 25 mM EDTA, 1 mg/ml proteinase K, pH 8) at
50 1C overnight, digested with ribonuclease A (10 mg/ml), and the
chromosomal DNA was extracted and analyzed by agarose gel
electrophoresis. To confirm and quantify apoptosis, we performed
Tunel assay (ApoAlert Assay kit; Clontech, LA Jolla, CA, USA) as
previously described.4 Briefly, cells grown on coverslips were fixed
with 4% formaldehyde for 30 min at 4 1C, permeabilized with 0.2%
Triton X-100 for 15 min at 4 1C, incubated with a mixture of
nucleotides and TdT enzyme for 60 min at 37 1C in a dark
humidified chamber, the reaction terminated with 2 SSC, and
the coverslips mounted on glass slides. Apoptotic nuclei were
detected by visualization with a fluorescent microscope. Slides were
examined in a blinded manner and apoptosis was quantified by
counting the number of Tunel-positive nuclei per 100 cells counted
in an average of five high power (original magnification  40) fields
in each section. Only cells displaying the characteristic morphology
of apoptosis, including nuclear fragmentation, nuclear condensa-
tion, and intensely fluorescent nuclei by Tunel assay, were counted as
apoptotic. Cells merely Tunel positive, but not matching the
morphological criteria, were not considered apoptotic.
To determine whether Daxx inhibition with antisense primers
affected caspase activation in vitro, we assayed for caspase-9 activity
using a fluorescent assay kit (BD Biosciences, San Jose, CA, USA), as
previously described.45 Caspase-9 was chosen to be assayed because
Daxx-dependent JNK phosphorylation activates the mitochondrial
apoptotic pathways.15,16 RPTECs treated were with sense or
antisense Daxx primers and the control group of cells was incubated
in the same medium but in the absence of any primers. Cells were
subjected to ATP depletion, incubated in cell lysis buffer, centrifuged
at 14,000 r.p.m., and the supernates were incubated with LEHD-
AMC (specific substrate for caspase-9) at 37 1C for 1 h. Caspase-9
activity was measured using a fluorometer. The specificity of
caspase-9 activity was documented by addition of caspase-9
inhibitor (Z-LEHD-FMK; BD Biosciences). The results are reported
as fold changes in caspase-9 activity from baseline non-ischemic
conditions.
Other materials and methods
All chemicals were purchased from Sigma unless otherwise specified.
The polyclonal antibody to Daxx (Upstate Biotechnologies, Lake
Placid, NY, USA) was used at 1:1,000 dilution; the monoclonal
antibody to Fas (Transduction Laboratories, Lexington, KY, USA)
was used at 1:1,000 dilution, and the polyclonal antibody to
phospho-JNK (which recognizes only the phosphorylated p46 and
p54 forms of JNK; from Upstate Biotechnologies) was used at
1:1,000 dilution. The monoclonal antibody to a-tubulin (Sigma)
was used at 1:10,000 dilution to confirm equal protein loading.
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